We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.66%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$70B
AUM Growth
+$9.17B
(+15%)
Cap. Flow
+$1.72B
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
24.19%
Holding
1,743
New
270
Increased
557
Reduced
362
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$575M |
| 2 |
Johnson & Johnson
JNJ
|
+$414M |
| 3 |
CHL
China Mobile Limited
CHL
|
+$331M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$241M |
| 5 |
Microsoft
MSFT
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$470M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$278M |
| 3 |
Eaton
ETN
|
+$269M |
| 4 |
PLDT
PHI
|
+$195M |
| 5 |
AB InBev
BUD
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.33% |
| 2 | Healthcare | 15.85% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 13.3% |
| 5 | Communication Services | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Estee Lauder
EL
$30.7B
| $104M | 0.15% |
501,276
-69,020
| -12% | -$13.4M |
|
127
Hershey
HSY
$35.9B
| $103M | 0.15% |
702,610
+195,362
| +39% | +$29M |
|
128
H&R Block
HRB
$5.61B
| $99.7M | 0.14% |
4,246,217
+863,289
| +26% | +$20.7M |
|
129
NXP Semiconductors
NXPI
$61.8B
| $98.5M | 0.14% |
773,912
+289,644
| +60% | +$33.6M |
|
130
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $97.7M | 0.14% |
2,177,718
+1,862,633
| +591% | +$80M |
|
131
Canadian National Railway
CNI
$76.9B
| $94.2M | 0.13% |
1,041,585
-3,672
| -0.4% | -$330K |
|
132
Bristol-Myers Squibb
BMY
$132B
| $93.7M | 0.13% |
1,459,933
+207,050
| +17% | +$11.9M |
|
133
KB Financial Group
KB
$42.5B
| $93M | 0.13% |
2,248,022
-95,289
| -4% | -$3.64M |
|
134
Cognizant
CTSH
$24.3B
| $91.6M | 0.13% |
1,477,725
+403,320
| +38% | +$24.9M |
|
|
SPLK
135
DELISTED
Splunk Inc
SPLK
| $90.7M | 0.13% |
605,500
-44,048
| -7% | -$5.78M |
|
|
UN
136
DELISTED
Unilever NV New York Registry Shares
UN
| $88.4M | 0.13% |
1,539,210
+754,210
| +96% | +$44.5M |
|
|
WUBA
137
DELISTED
58.com Inc
WUBA
| $88M | 0.13% |
1,360,239
+164,136
| +14% | +$9.23M |
|
138
Cognex
CGNX
$10.4B
| $86.1M | 0.12% |
1,536,500
-55,600
| -3% | -$2.88M |
|
139
BHP
BHP
$218B
| $84.7M | 0.12% |
1,736,076
-9,930
| -0.6% | -$451K |
|
140
American Express
AXP
$228B
| $84.1M | 0.12% |
675,276
-126,891
| -16% | -$15.2M |
|
|
CAF
141
Morgan Stanley China A Share Fund
CAF
$325M
| $83.7M | 0.12% |
3,855,595
-47,825
| -1% | -$1.02M |
|
142
Microchip Technology
MCHP
$40.7B
| $82.6M | 0.12% |
1,577,000
-57,000
| -3% | -$2.75M |
|
143
UnitedHealth
UNH
$383B
| $79.6M | 0.11% |
270,859
-1,803
| -0.7% | -$472K |
|
144
Boston Scientific
BSX
$68.4B
| $78.1M | 0.11% |
1,728,077
-168,682
| -9% | -$7.06M |
|
145
Citizens Financial Group
CFG
$30.3B
| $76.2M | 0.11% |
1,877,604
+1,087,818
| +138% | +$40.7M |
|
146
Silicon Motion
SIMO
$8.65B
| $76.2M | 0.11% |
1,501,972
+31,324
| +2% | +$1.34M |
|
147
Bank of America Series L
BAC.PRL
$3.96B
| $75.7M | 0.11% |
52,252
| – | – |
|
148
Omnicom Group
OMC
$21.8B
| $75.5M | 0.11% |
931,783
+55,200
| +6% | +$4.33M |
|
149
Eli Lilly
LLY
$1.03T
| $73.1M | 0.1% |
555,903
-272,720
| -33% | -$31.6M |
|
150
IBM
IBM
$209B
| $72.1M | 0.1% |
562,571
+15,842
| +3% | +$2.06M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Lazard Asset Management held 1,743 positions worth $70B, up 15% from $60.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management's Q4 2019 filing shows 270 new, 557 increased, 362 reduced and 215 closed positions. Its largest new stake was West Pharmaceutical: 89,164 shares worth $13.4M. The largest sale was NetEase, an estimated $470M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Lazard Asset Management's largest Q4 2019 buy was West Pharmaceutical: 89,164 shares worth $13.4M.
- Lazard Asset Management added most to McDonald's in Q4 2019, an estimated $575M increase.
- Lazard Asset Management's biggest Q4 2019 reduction was NetEase, cutting an estimated $470M.
- Lazard Asset Management fully exited Corelogic, Inc. in Q4 2019, selling an estimated $68.4M.
- Lazard Asset Management's ten largest holdings make up 24% of its $70B portfolio in Q4 2019.
- Lazard Asset Management opened 270 new positions and closed 215 in Q4 2019.
- Lazard Asset Management's portfolio value rose 15% quarter-over-quarter to $70B.
Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.